Investors & Media

Investor FAQ

Cytokinetics is traded on the NASDAQ Global Markets under the symbol CYTK.
You will need to contact a licensed stockbroker to purchase shares of Cytokinetics.
Cytokinetics' headquarters is located in South San Francisco, CA. Our mailing address is 350 Oyster Point Blvd, South San Francisco, CA 94080.
Cytokinetics, Inc. was incorporated in Delaware in 1997.
Cytokinetics' initial public offering was on April 29, 2004.
As of April 2023, Cytokinetics had 415 employees.
Our transfer agent is Computershare
P.O. Box 43078
Providence, RI 02940-3078
Phone (800) 837-8091
TDD for Hearing Impaired (800) 952-9245
Foreign Shareholders (201) 680-6578
In these instances contact our Transfer Agent:

Standard USPS
P. O. Box 30170
College Station TX 77842

211 Quality Circle, Suite 210
College Station TX 77845 Phone (800) 837-8091
TDD for Hearing Impaired (800) 952-9245
Foreign Shareholders (201) 680-6578
The date of each upcoming quarterly earnings call will be announced two weeks in advance of when it is scheduled to take place.
Our annual meeting of stockholders takes place during the second quarter of the year.
Our Form 10-Qs, Form 10-Ks, Form 8-Ks and other reports, when available, are listed on the SEC's web site,, please search on "Cytokinetics" or visit the Investor Center's SEC links within this website to visit the SEC's web site.
The sell-side analysts that cover Cytokinetics are listed within the Analyst Coverage Page of this website.
Cytokinetics' independent auditors are Ernst & Young LLP.
Cytokinetics' external legal advisors is Cooley LLP.
Please contact:
Investor Relations
Cytokinetics, Inc.
350 Oyster Point Blvd
South San Francisco, CA 94080
Phone: 650-624-3060